Pharmacy Pearls: Best Practice Guidance for Reduction of Outpatient Migraine in Adults

April 15th, 2021 | Pharmacy Pearls•Migraine

This edition of Pharmacy Pearls is to assist with challenges faced in clinical practice managing migraineurs and with the approval of new agents to help prevent migraine. AHP assembled a workgroup to create a best practice guidance document focused on the reduction of outpatient migraines in adults. Partnering with Neurology and PCP stakeholders, we developed a document that concisely synthesizes recent evidence and expert recommendations.

As always, we welcome any questions or feedback you may have. Just email the Pharmacy Team.

Taking too long?

Reload document

Open in new tab

Download PDF [223.28 KB]

135 Corporate Woods, Suite 320
Rochester, New York 14623-1466

Phone: (585) 758-7823
Fax: (585) 424-1268

Website by:

This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP). An offer will only be made by means of a confidential private placement memorandum and subscription agreement.

ABI Value	Interpretation	Recommendation
Greater than 1.4	Calcification/vessel hardening	Refer to vascular specialist
1.0 - 1.4	Normal	None
0.9 - 1.0	Acceptable	None
0.8 - 0.9	Some arterial disease	Treat risk factor
0.5 - 0.8	Moderate arterial disease	Refer to vascular specialist
Less than 0.5	Severe arterial disease	Refer to vascular specialist

Pharmacy Pearls: Best Practice Guidance for Reduction of Outpatient Migraine in Adults

Pharmacy Pearls: Best Practice Guidance for Reduction of Outpatient Migraine in Adults

GENERAL COVID-19 INFORMATION